Cyxone AB (FRA:4CX) Net Change in Cash : €-0.74 Mil (TTM As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Cyxone AB Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Cyxone AB's Net Change in Cash for the three months ended in Jun. 2024 was €-0.53 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.74 Mil.

Cyxone AB Net Change in Cash Historical Data

The historical data trend for Cyxone AB's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyxone AB Net Change in Cash Chart

Cyxone AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

3.94

-0.53

-2.63

-0.01

-1.05

Cyxone AB Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Net Change in Cash	Get a 7-Day Free Trial															-0.68	-0.55	0.81	-0.46	-0.53

Cyxone AB Net Change in Cash Calculation

Cyxone AB's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-1.734	+	-0.588	+	1.271	+	0.004
	=	-1.05

Cyxone AB's Net Change in Cash for the quarter that ended in Jun. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -0.426 + -0.088 + -0.017 + -0

= -0.53

Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.74 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cyxone AB Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Cyxone AB's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Cyxone AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cyxone AB (FRA:4CX) » Definitions » Net Change in Cash

Comparable Companies

OSTO:2CUREX XSAT:WNT OSTO:DIABIO OSTO:LIDDS OSTO:ZICC XSAT:ALTE OSTO:FLUI OSTO:LPGO OSTO:QUIA XSAT:APTA VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE

Traded in Other Exchanges

N/A

Address

Hyllie Boulevard 34, Malmo, SWE, 215 32

Website

https://www.cyxone.com

Cyxone AB is a clinical biotech company with a portfolio of immunomodulating drugs for the treatment of autoimmune diseases such as multiple sclerosis (MS) and rheumatoid arthritis (RA). The product candidates of the company include T20K and Rabeximod.

Cyxone AB Headlines

No Headlines